New EU health commissioner promises to balance interests of public health and pharma
This article was originally published in Scrip
Executive Summary
The future European Commissioner for health and consumer policy, Malta's John Dalli, has pledged to defend the interests of patients and consumers while ensuring that the pharmaceutical industry remains competitive.
You may also be interested in...
EU Ministers Want Decisive Action On Medicines Access & Shortages
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
EMA Prepares Approval Verdict On Beovu, Idhifa, Recarbrio
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
New EU Commissioner Outlines Plans To Tackle Shortages
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
Need a specific report? 1000+ reports available
Buy Reports